Patient Safety and Clinical Implications of Hospital Onset Bacteremia and Its Sources

Hospital Onset Bacteremia & Fungemia (HOB) is a new metric proposed by the CDC for NHSN volunteer reporting this calendar year. We aim to answer three main questions based on three recent ICHE publications: 1. what is HOB vs CLABSI; 2. How do urine sources of CAUTI and non-catheter Hospital Onset UTIs contribute to HOB; and 3. How to leverage existing infrastructure mandated by CMS to improve HOB care.
Click here to watch the presentation.
Learning Objectives:
  1. Understand the definition of the newly planned metric hospital onset bacteremia and fungemia (HOB)
  2. Describe the patient safety risks and healthcare system economic implications of HOB and CLABSI
  3. Describe how CAUTIs and non-catheter UTIs play a role in HOB events and delineate the clinical issues that need to be addressed
  • Samantha Bastow, PharmD, MBA (Associate Director, Medical Affairs – Becton Dickinson and Company)
  • Kalvin Yu, MD, FIDSA (Vice President, Medical Affairs North America – Becton Dickinson and Company)
  • Rachel Long, MT M Ed. CIC, FAPIC (AVP Infection Prevention, HCA Healthcare)